InsiderTrades

Form 4 for GALT GALECTIN THERAPEUTICS INC

Accepted 2025-06-11 00:00:00 ET · period of report 2025-02-03 · accession 0001641172-25-014756 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-06-11 2025-06-06 GALT CZIRR JAMES C 10% M - OptEx $2.16 +323.1K 965.5K +50% +$699.3K
DM 2025-06-11 2025-02-03+ GALT CZIRR JAMES C 10% G - Gift — -20.0K 721.4K -3% —
D 2025-06-11 2025-03-31 GALT CZIRR JAMES C 10% J - Other $6.00 +1,000 722.4K +0.1% +$6,000
DM 2025-06-11 2025-06-06 GALT CZIRR JAMES C 10% M - OptEx $0.00 -323.1K 40.0K -89% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-06 M A 46,875 $2.39 800,541 D — —
2 Common Common Stock 2025-06-06 M A 40,000 $1.98 1,005,541 D — —
3 Common Common Stock 2025-02-03 G D 10,000 — 731,416 D — — (F3) No consideration was received for the shares, which were transferred by gift to relatives.
4 Common Common Stock 2025-02-04 G D 10,000 — 721,416 D — — (F3) No consideration was received for the shares, which were transferred by gift to relatives.
5 Common Common Stock 2025-03-31 J A 1,000 $6.00 722,416 D — — (F1) Common stock received in satisfaction of $6,000 of dividends due on Series A Convertible Preferred Stock owned by James C. Czirr pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividend was paid on 3/31/2025. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend.
6 Common Common Stock 2025-06-06 M A 31,250 $0.89 753,666 D — —
7 Common Common Stock 2025-06-06 M A 40,000 $1.11 1,045,541 D — —
8 Common Common Stock 2025-06-06 M A 25,000 $4.72 825,541 D — —
9 Common Common Stock 2025-06-06 M A 30,000 $2.86 855,541 D — —
10 Common Common Stock 2025-06-06 M A 40,000 $2.11 895,541 D — —
11 Common Common Stock 2025-06-06 M A 70,000 $2.11 965,541 D — —
12 Derivative Stock Option (right to buy) 2025-06-06 M D 40,000 $0.00 0 D $1.11 · — to 2025-06-07 40,000 Common Stock (F4) Stock options were exercisable at time of exercise.
13 Derivative Stock Option (right to buy) 2025-06-06 M D 70,000 $0.00 80,000 D $2.11 · — to 2025-06-07 70,000 Common Stock (F4) Stock options were exercisable at time of exercise.
14 Derivative Stock Option (right to buy) 2025-06-06 M D 40,000 $0.00 150,000 D $2.11 · — to 2025-06-07 40,000 Common Stock (F4) Stock options were exercisable at time of exercise.
15 Derivative Stock Option (right to buy) 2025-06-06 M D 30,000 $0.00 190,000 D $2.86 · — to 2025-06-07 30,000 Common Stock (F4) Stock options were exercisable at time of exercise.
16 Derivative Stock Option (right to buy) 2025-06-06 M D 25,000 $0.00 220,000 D $4.72 · — to 2025-06-07 25,000 Common Stock (F4) Stock options were exercisable at time of exercise.
17 Derivative Stock Option (right to buy) 2025-06-06 M D 46,875 $0.00 245,000 D $2.39 · — to 2025-06-07 46,875 Common Stock (F4) Stock options were exercisable at time of exercise.
18 Derivative Stock Option (right to buy) 2025-06-06 M D 31,250 $0.00 291,875 D $0.89 · — to 2025-06-07 31,250 Common Stock (F4) Stock options were exercisable at time of exercise.
19 Derivative Stock Option (right to buy) 2025-06-06 M D 40,000 $0.00 40,000 D $1.98 · — to 2025-06-07 40,000 Common Stock (F4) Stock options were exercisable at time of exercise.